Mani Narasimhan - 25 Jul 2024 Form 3 Insider Report for TRxADE HEALTH, INC (SCNX)

Role
Director
Signature
/s/ Louis Kern, as attorney-in-fact for Narasimhan Mani
Issuer symbol
SCNX
Transactions as of
25 Jul 2024
Net transactions value
$0
Form type
3
Filing time
05 Aug 2024, 21:23:00 UTC
Next filing
12 Mar 2026

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MEDS Common Stock, par value $0.00001 57,977 25 Jul 2024 By Srivatsav, LLC F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MEDS Series X Non-Voting Convertible Preferred Stock 25 Jul 2024 Common Stock 1,357,538 $0.000000 By Srivatsav, LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities of TRxADE HEALTH, INC. (the "Issuer") were issued to Narasimhan Mani in connection with the closing of the acquisition of Scienture, Inc. ("Scienture") by the Issuer on July 25, 2024 (the "Merger") pursuant to an Agreement and Plan of Merger entered into by the Issuer, certain subsidiaries of the Issuer, and Scienture (the "Merger Agreement").
F2 These shares of the Issuer's Series X Non-Voting Convertible Preferred Stock, par value $0.00001 per share (the "Preferred Stock"), have no expiration date. On the 20th calendar day following the mailing of an information statement on Schedule 14C that the Issuer is filing with the Securities and Exchange Commission and mailing to its stockholders in connection with the closing of the Merger, these shares of Preferred Stock will automatically convert on a 1-for-1 basis into fully paid and nonassessable shares of the Issuer's common stock, par value $0.00001.
F3 These shares of Preferred Stock are owned directly by Srivatsav, LLC ("Srivatsav"). As the Managing Member of Srivatsav, Mr. Mani may be deemed to be the indirect beneficial owner of securities held by Srivatsav. Mr. Mani disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Remarks:

Exhibit List - Exhibit 24.1: Power of Attorney (Narasimhan Mani)